New Daily Persistent Headache
📧 Sign up to get email alerts when something new happens for New Daily Persistent Headache.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: New Daily Persistent Headache Survey
A survey-based clinical trial examining New Daily Persistent Headache (NDPH) conducted by the University of Texas Health Science Center, Hou…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: China HeadAche DIsorders RegiStry
A China-based headache disorders registry trial is currently recruiting, covering primary headache disorders and several related conditions …
-
CLINICAL_TRIALS withdrawal · 2025-07-24Clinical Trial Update: Nerivio Device for Treatment of New Daily Headache Persistence (NDHP) [NA]
A clinical trial evaluating the Nerivio device for New Daily Persistent Headache (NDPH) has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-05-06Clinical Trial Update: Endogenous Modulation and Central Sensitization in New Daily Persistent Headache ( NDPH ) in Children [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial investigating endogenous modulation and central sensitization in New Daily Persistent Headache (NDPH) i…
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: OnabotulinumtoxinA for the Treatment of New Daily Persistent Headache: an Open Label Study [Phase 2]
This is a Phase 2 open-label study evaluating Botox (onabotulinumtoxinA) for New Daily Persistent Headache, sponsored by St. Luke's-Roosevel…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.